NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/27/2025
Back to search
Official data from USPTO
NUO THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
NUO THERAPEUTICS
ST13
US500000086385361Class
5
Filing
86385361
Registration
4791939
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
10/28/2025
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
09/04/2014
Registration date
08/11/2015
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/27/2025
Last transaction
10/28/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/14/2014
First use in commerce
12/05/2014
Drawing code
4
Owner type
03
Owner location
GAITHERSBURG, MD
Examiner
EULIN,INGRID C
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
NUO THERAPEUTICS, INC.
Cytomedix, Inc.
Representatives
Camille M. Miller COZEN O'CONNOR
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary preparation for topical application for use as an aid in wound healing; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; diagnostic reagents for medical and medicinal use; clinical medical reagents; chemical reagents for medical or veterinary purposes; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; biological molecules to assist in the development of tissue; hemostatic gel matrix preparations for treating wounds; wound dressingspledgets; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; biological tissue cultures for medical purposes; biological tissue grafts; human allograft bone and tissue; implants comprising living tissue; media for use in the augmentation of boneblood and tissue for medical purposes; natural biomaterials for augmentation of boneblood and tissue for medical purposes; processed human donor skin for the replacement of soft tissue; surgical implants comprising living tissue
Publications
History of USPTO decisions and trademark events.
38 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/27/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/27/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/27/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
07/08/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/11/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/18/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/18/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/18/2022
E815
TEAS SECTION 8 & 15 RECEIVED
01/11/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/11/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/23/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
08/11/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/28/2015
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/08/2015
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/07/2015
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/10/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/10/2015
IUAF
USE AMENDMENT FILED
05/12/2015
EISU
TEAS STATEMENT OF USE RECEIVED
05/12/2015
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/12/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/17/2015
PUBO
PUBLISHED FOR OPPOSITION
03/17/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/25/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/10/2015
ALIE
ASSIGNED TO LIE
02/10/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/23/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/20/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/19/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/19/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/11/2014
GNRT
NON-FINAL ACTION E-MAILED
12/11/2014
CNRT
NON-FINAL ACTION WRITTEN
12/11/2014
DOCK
ASSIGNED TO EXAMINER
12/02/2014
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/05/2014
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/05/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/15/2014
NWAP
NEW APPLICATION ENTERED
09/08/2014
Continuous trademark protection
Get notified about every new filing that threatens NUO THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.